Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Cash Flow: 2021-2025

Historic Net Cash Flow for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$2.7 million.

  • MDxHealth's Net Cash Flow fell 112.19% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 326.20%. This contributed to the annual value of $18.2 million for FY2024, which is 1684.74% up from last year.
  • Per MDxHealth's latest filing, its Net Cash Flow stood at -$2.7 million for Q3 2025, which was up 82.49% from -$15.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Cash Flow registered a high of $21.8 million during Q3 2024, and its lowest value of -$17.3 million during Q1 2022.
  • Its 3-year average for Net Cash Flow is $379,000, with a median of -$4.6 million in 2023.
  • As far as peak fluctuations go, MDxHealth's Net Cash Flow skyrocketed by 578.91% in 2024, and later plummeted by 112.19% in 2025.
  • MDxHealth's Net Cash Flow (MRQ) stood at -$9.7 million in 2021, then grew by 8.06% to -$8.9 million in 2022, then grew by 29.52% to -$6.3 million in 2023, then skyrocketed by 259.40% to $10.1 million in 2024, then crashed by 126.48% to -$2.7 million in 2025.
  • Its last three reported values are -$2.7 million in Q3 2025, -$15.2 million for Q2 2025, and $14.3 million during Q1 2025.